Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
March 20, 2024
HERCULES, Calif. -- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Roop K. Lakkaraju will join the company as its new Executive Vice President and Chief Financial Officer, effective April 15, 2024. Mr. Lakkaraju joins Bio-Rad from Benchmark Electronics, a multi-national leader [...]
March 20, 2024
Expansion to SemaCyte Microcarrier platform enables optical barcoding and pooling of adherent cells to augment drug discovery high-content imaging and other screening processes Access available through Semarion’s Early Adopter Program Cambridge, UK: Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening [...]
The future of reaction screening is here
March 20, 2024
~ Technobis launches game-changing reaction screening instrument ~ Laboratory technology developer Technobis has released ReactALL™, an innovative benchtop multiple reactor system for medium throughput experimentation, helping scientists tap into the under-utilized nights and weekends. Available globally now, ReactALL™ uses novel integrated automated sampling technology to accelerate chemical reaction screening, optimisation, route scouting, reaction profiling and [...]
JEOL CRYO-FIB-SEM Enables Specimen Preparation for Cryo-Electron Microscopy
March 19, 2024
Peabody, MA --- JEOL is pleased to announce the introduction of a new CRYO-FIB-SEM, a Focused Ion Beam milling specimen preparation tool specifically designed for creating thin, frozen samples for Cryo-Electron Microscopy. The new system complements JEOL’s existing Cryo-TEM technology and provides a comprehensive solution for preparing and imaging vitreous frozen biological and biopolymer samples to be [...]
March 19, 2024
New Universal DeepVariant is one microservice compatible across multiple sequencing platforms and is designed to deliver more than 50x acceleration compared to CPU MOUNTAIN VIEW, Calif. -- -DNAnexus, Inc., the provider of the Precision Health Data Cloud, today announced that it is integrating new NVIDIA NIM and CUDA-X microservices. These microservices are designed to allow [...]
March 19, 2024
Instrument Breaks the Boundaries of EV Detection, Providing Access to New Data Points INDIANAPOLIS – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation and a subsidiary of Danaher Corporation (NYSE: DHR), continues to lead the way with first-to-market concepts with the launch of the CytoFLEX nano Flow Cytometer – the first purpose-built [...]
March 19, 2024
Image caption: UC Enuity ultramicrotome Wetzlar, Germany – Leica Microsystems, a leading provider of microscopy and scientific instrumentation, has launched UC Enuity, the next generation ultramicrotome for electron microscopy sample preparation. Building upon the EM UC7 and 70 years of ultramicrotomy history, UC Enuity introduces a significant advancement to the field. With an emphasis on [...]
Highly consistent collagen fibre scaffold for 3D cell culture
March 19, 2024
Produced using a patented dry-spinning technology - CollaFibR™ from AMSBIO is a highly consistent collagen fibre matrix that closely mimics the biomechanical and biochemical properties of natural collagen scaffolds, offering a highly accurate representation of in-vivo conditions. These innovative collagen fibres are seamlessly produced on a commercial scale using an automated state-of-the-art Good Manufacturing Process, [...]
March 19, 2024
MENADNA Inc., has entered into an exclusive partnership with ProPhase Labs' subsidiary, Nebula Genomics, aiming to advance genomic testing in Jordan, Oman, and Iraq. This collaboration will leverage Nebula Genomics' advanced sequencing technologies and MENADNA's bioinformatics capabilities to improve the quality and relevance of genomic data in these historically underserved regions. Pleasanton, CA -- MENADNA [...]
Ampersand Capital Partners Acquires Biologos
March 19, 2024
GLENDALE HEIGHTS, Ill. -- Ampersand Capital Partners ("Ampersand"), a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, announced today the acquisition of Biologos LLC ("Biologos"), a full-service manufacturer of custom and standard cell culture media, reagents, buffers, enzymes, and sera. The partnership with Ampersand will include investments to expand Biologos' [...]

